On the filings, Nike (NKE) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
High-quality brand mid-turnaround: earnings halved and FY26 faces tariff/margin pain, but a fair price and a fortress balance sheet earn patience — not new money.
Brand in multi-year decline: revenue shrinking, deep losses, equity eroding and $600M of debt due — too broken to own now.
| Metric | NKE | UAA |
|---|---|---|
| Fundamentals score | 61 | 33 |
| Revenue growth (YoY) | -9.8% | -3.8% |
| Net income growth (YoY) | -43.5% | -146.3% |
| Net margin | 7.0% | -10.0% |
| Return on equity | 24.4% | -35.0% |
| ROIC (est.) | — | -4.9% |
| Liabilities / Equity | — | 2.12 |
| Piotroski F-score | 4 / 9 | 3 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 1, 2026, 9:54 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 11:44 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.